Cargando…
Discovery of a capuramycin analog that kills non-replicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors
Capuramycin (1) and its analogs are strong translocase I (MurX/MraY) inhibitors. In our SAR studies of capuramycin analogs against M. tuberculosis (Mtb), we observed for the first time that a capuramycin analog, UT-01320 (3) killed non-replicating (dormant) Mtb at low concentrations under low-oxygen...
Autores principales: | Siricilla, Shajila, Mitachi, Katsuhiko, Wan, Bajoie, Franzblau, Scott G., Kurosu, Michio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382465/ https://www.ncbi.nlm.nih.gov/pubmed/25269459 http://dx.doi.org/10.1038/ja.2014.133 |
Ejemplares similares
-
A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry
por: Yang, Dong, et al.
Publicado: (2016) -
An improved total synthesis of tunicamycin V
por: Mitachi, Katsuhiko, et al.
Publicado: (2023) -
Biosynthetic and Synthetic Strategies for Assembling Capuramycin-Type Antituberculosis Antibiotics
por: Biecker, Ashley L., et al.
Publicado: (2019) -
A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studies
por: Mitachi, Katsuhiko, et al.
Publicado: (2019) -
Novel FR-900493 Analogues That Inhibit the Outgrowth
of Clostridium difficile Spores
por: Mitachi, Katsuhiko, et al.
Publicado: (2018)